Zaktady Farmaceutyczne POLPHARMA - search results

ticagrelor inovamed 60 mg

inovamed pharma ltd, israel - ticagrelor - film coated tablets - ticagrelor 60 mg - ticagrelor - ticagrelor inovamed , co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with - acute coronary syndromes (acs) or- a history of myocardial infarction (mi) and a high risk of developing an atherothrombotic event. limitations of use: 90 mg twice daily during the first year after an acs event followed by 60 mg twice daily for additional 2 years.

Israel - English - Ministry of Health

ticagrelor inovamed 90 mg

inovamed pharma ltd, israel - ticagrelor - film coated tablets - ticagrelor 90 mg - ticagrelor - ticagrelor inovamed , co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with - acute coronary syndromes (acs) or- a history of myocardial infarction (mi) and a high risk of developing an atherothrombotic event. limitations of use: 90 mg twice daily during the first year after an acs event followed by 60 mg twice daily for additional 2 years.

European Union - English - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimethyl fumarate - multiple sclerosis, relapsing-remitting - immunosuppressants - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.